Kite Pharma, Inc.
SEC CIK 1510580 · KITE · last insider filing 2017-10-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Champsi Farah | Director | filed 2014 - 2017 |
| Kazam Joshua A | Director | filed 2014 - 2017 |
| Doumani ROY | Director | filed 2014 - 2017 |
| Belldegrun Arie | Director · Chairman, President and CEO | filed 2014 - 2017 |
| Clark IAN T | Director | filed 2017 - 2017 |
| Peacock Jonathan M | Director | filed 2014 - 2017 |
| Humer Franz B | Director | filed 2015 - 2017 |
| Ruchefsky Steven B | Director | filed 2014 - 2017 |
| Nussbaum Ran | Director | filed 2014 - 2017 |
| Witte Owen N. | Director | filed 2017 - 2017 |
| Bonderman David | Director | filed 2014 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Butitta Cynthia M | Chief Operating Officer | filed 2014 - 2017 |
| Kim Helen Susan | EVP, Business Development | filed 2015 - 2017 |
| Wiezorek Jeffrey | VP Clinical Development | filed 2014 - 2017 |
| Chang David D | EVP, R&D, Chief Medical Off. | filed 2014 - 2017 |
| Tomasello Shawn | Chief Commercial Officer | filed 2015 - 2017 |
| Moore Timothy L. | EVP, Technical Operations | filed 2016 - 2017 |
| Jenkinson Paul L | Chief Financial Officer | filed 2016 - 2017 |
| Roberts Margo R | Chief Scientific Officer | filed 2014 - 2016 |
| Sproule Rizwana F | VP Regulatory Affairs | filed 2014 - 2016 |
| Better Marc | VP, Product Sciences | filed 2014 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.